[29P] Testing, property and stability of medicinal formulation,Novel formulations/Development of novel medicines and formulations/Dispensing, prescription audit and ordering,Drug management,Risk management/Formulation testing・In-house formulation・Management of intravenous and enteral nutrition/Others

8:30 AM - 3:00 PM JST(11:30 PM - 6:00 AM UTC)

[29PA-372] Prescribing changes after the COVID-19 epidemic readable from NDB open data

○Kayo Machihara¹, Shinya Hamada¹, Akira Nakatsuma¹, Shiho Takagishi¹, Yoichi Kawasaki¹ (1. Kagawa Sch.Pharm.Sci.,Tokushima Bunri Univ.)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.